OrbiMed’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Sell
243,006
-27,000
-10% -$347K 0.08% 100
2025
Q4
$2.79M Sell
270,006
-1,653,849
-86% -$14.9M 0.06% 95
2025
Q3
$11.4M Hold
1,923,855
0.27% 72
2025
Q2
$14.5M Hold
1,923,855
0.36% 50
2025
Q1
$14.6M Sell
1,923,855
-18,700
-1% -$179K 0.35% 52
2024
Q4
$23.7M Buy
1,942,555
+872,500
+82% +$12.5M 0.49% 46
2024
Q3
$17.9M Sell
1,070,055
-77,600
-7% -$1.38M 0.33% 68
2024
Q2
$20M Buy
1,147,655
+630,049
+122% +$13.4M 0.4% 61
2024
Q1
$8.82M Sell
517,606
-27,242
-5% -$421K 0.16% 83
2023
Q4
$5.55M Hold
544,848
0.11% 89
2023
Q3
$4.93M Hold
544,848
0.11% 99
2023
Q2
$5.86M Sell
544,848
-60,539
-10% -$643K 0.11% 98
2023
Q1
$6.19M Sell
605,387
-31,900
-5% -$352K 0.12% 99
2022
Q4
$6.72M Hold
637,287
0.13% 84
2022
Q3
$8.17K Sell
637,287
-33,500
-5% -$451K 0.15% 90
2022
Q2
$8.6K Hold
670,787
0.16% 98
2022
Q1
$7.02M Sell
670,787
-134,254
-17% -$1.81M 0.11% 110
2021
Q4
$12.4M Sell
805,041
-341,104
-30% -$6.8M 0.16% 109
2021
Q3
$25.9M Hold
1,146,145
0.28% 85
2021
Q2
$29.5M Hold
1,146,145
0.3% 77
2021
Q1
$47.8M Buy
+1,146,145
New +$46.5M 0.45% 64

Other funds holding CGEM